Showing results (131-140 of 527) with videos related to
Sort By:
Pageof 53
Therapeutic Advances in Drug Safety|January 5, 2026
Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System databaseXiaomo Xiong, Zhanghe Chen, Bingfang YanTherapeutic Advances in Drug Safety|September 2, 2021
Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques dataLevin Thomas, Sumit Raosaheb Birangal, Rajdeep Ray, et al.Therapeutic Advances in Drug Safety|April 30, 2015
Menopausal hormone therapy and breast cancer mortality: clinical implicationsRowan T Chlebowski, Garnet L AndersonTherapeutic Advances in Drug Safety|April 30, 2015
Bleeding risk with systemic thrombolytic therapy for pulmonary embolism: scope of the problemMitchell J Daley, Manasa S Murthy, Evan J PetersonTherapeutic Advances in Drug Safety|October 23, 2019
Deferasirox in thalassemia: a comparative study between an innovator drug and its copy among a sample of Iraqi patientsAqil M Daher, Hayder Al-Momen, Shaymaa Kadhim JasimTherapeutic Advances in Drug Safety|June 20, 2020
A mixed methods analysis of lithium-related patient safety incidents in primary careRichard Simon Young, Paul Deslandes, Jennifer Cooper, et al.Therapeutic Advances in Drug Safety|August 5, 2021
The safety of ceftolozane-tazobactam for the treatment of acute bacterial infections: a systemic review and meta-analysisLi-Ting Wang, Wei-Ting Lin, Chih-Cheng Lai, et al.Therapeutic Advances in Drug Safety|August 5, 2021
Inappropriate medications and physical function: a systematic reviewElizabeth Manias, Md Zunayed Kabir, Andrea B MaierTherapeutic Advances in Drug Safety|April 7, 2017
Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomesJose Martinez-Raga, Amparo Ferreros, Carlos Knecht, et al.Therapeutic Advances in Drug Safety|March 4, 2017
Response to treatment and adverse events associated with use of recombinant activated factor VII in children: a retrospective cohort studyJames D Cooper, Arthur K RitcheyPageof 53